MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

In this Discussion

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

A Heavy Loss In Fidelity's Pursuit Of The Perfect Tomato

Comments

  • msf
    Given Fidelity's crop of funds (more 1* than 5*, more 2* than 4*), what's a few more rotten tomatoes?
  • BenWPBenWP
    Back in the day, the FlavrSavr tomato was going to be the next big thing in AgBiotech. The genetically modified fruit was supposed to keep in a ripened state for three weeks on the shelf. The company, Calgene, cost shareholders (me included) a pretty penny. Apparently Monsanto now owns the technology and the unenviable task of convincing a skeptical public that it would not put Frankenfood on the market.
Sign In or Register to comment.